Inventiva (IVEVF) Other Non-Current Liabilities (2023 - 2025)
Inventiva (IVEVF) posted Other Non-Current Liabilities of $1.4 million for Q4 2025, up 8.95% on a QoQ basis from $1.3 million in Q2 2025, and up 25.93% year-over-year from $1.1 million in Q4 2024.
Analysis
Inventiva (IVEVF) Other Non-Current Liabilities (2023 - 2025) Analysis & Trends
Inventiva has reported Other Non-Current Liabilities for 3 years, with the latest figure at $1.4 million in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities rose 25.93% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 25.93% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 25.93% from the prior year.
- Other Non-Current Liabilities was $1.4 million for Q4 2025 at Inventiva, up from $1.3 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.4 million in Q4 2025, with the low at $1.1 million in Q4 2024.
- Average Other Non-Current Liabilities over 3 years is $1.2 million, with a median of $1.1 million recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities fell 0.68% in 2024, then increased 25.93% in 2025.
- Over 3 years, Other Non-Current Liabilities stood at $1.1 million in 2023, then decreased by 0.68% to $1.1 million in 2024, then grew by 25.93% to $1.4 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $1.4 million (Q4 2025), $1.3 million (Q2 2025), and $1.1 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |